Publications

BibTex format

@article{Chakrabarti:2016:10.1097/CPM.0000000000000150,
author = {Chakrabarti, AM and Jacobs, J and Molyneaux, PL and Devaraj, A and Chua, F},
doi = {10.1097/CPM.0000000000000150},
journal = {Clinical Pulmonary Medicine},
pages = {151--156},
title = {Smoking-related interstitial lung disease},
url = {http://dx.doi.org/10.1097/CPM.0000000000000150},
volume = {23},
year = {2016}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Chronic or heavy smoking can lead to different forms of pathologic remodeling in the airways and distal lung. There is an 8% to 19% prevalence of interstitial lung disease (ILD) in chronic smokers who were unaware that they had a lung disorder. Descriptive pathologic and radiologic analyses have enabled a number of clinical diseases to be identified and grouped within a range of smoking-related ILDs. We review the radiology, pathology, and clinical management of pulmonary Langerhans cell histiocytosis, respiratory bronchiolitis-associated ILD, and desquamative interstitial pneumonia. We discuss the difficulties of classification and also where the new entity of airspace enlargement with fibrosis fits into the current grouping. The prognosis for these conditions is variable depending on the intrinsic behavior of each condition. Smoking cessation is the first-line therapy of choice for any smoking-related ILD, whereas treatment with corticosteroids and other agents forms an important, but occasionally futile, intervention.
AU  - Chakrabarti,AM
AU  - Jacobs,J
AU  - Molyneaux,PL
AU  - Devaraj,A
AU  - Chua,F
DO  - 10.1097/CPM.0000000000000150
EP  - 156
PY  - 2016///
SN  - 1068-0640
SP  - 151
TI  - Smoking-related interstitial lung disease
T2  - Clinical Pulmonary Medicine
UR  - http://dx.doi.org/10.1097/CPM.0000000000000150
UR  - http://hdl.handle.net/10044/1/75859
VL  - 23
ER  -

Download

ProfessorPhilipMolyneaux

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)